ONCOLOGY RESEARCH

Decoding Tumor Dynamics
Through Intelligence

Advancing label-free cancer spheroid analysis with XAI-validated deep learning architectures.

DEPLOYED ARCHITECTURES

Core Analytical Engines

Spheroid-Net v1.4

Viability Profiler

CNN optimized for phase-contrast imagery. Identifies necrotic cores and calculates viability scores.

Accuracy95.4%
XAIGrad-CAM++

Resist-Alpha

Resistance Forecasting

Vision Transformer (ViT) architecture that predicts drug resistance by correlating morphological changes.

Accuracy92.1%
XAIAttention

Core Methodologies

Phase-Contrast Viability

Non-invasive prediction of cellular states without destructive chemical assays, allowing for longitudinal monitoring.

XAI Validation

Utilizing Grad-CAM and TCAV to verify that neural attention aligns with biological markers like necrotic cores.

Domain Adaptation

Ensuring model robustness across diverse imaging platforms and varying laboratory conditions.

Selected Publications

MAR 2025

Towards precision medicine using biochemically triggered cleavable conjugation

comprehensive classification of the intrinsic physicochemical differences found in pathological areas and their applications in drug delivery, prodrug activation, imaging, and theranostics for future personalised medicines.

Nature Communications Chemistry
FEB 2026

Programmable multispecific polybodys for T cell engagement and checkpoint modulation enhancing solid tumor immunotherapy

Multispecifc polybodys achieve solid tumor inhibition and immune cell infiltration in mice solid tumor models.

Chemical Engineering Journal
JAN 2026

Seeing through collagen: integrative pro-regenerative corneal implants for clearer future

This review provides a comprehensive analysis of the current state and the future strategies to optimize collagen.

npj Regenerative Medicine
DEC 2025

Gold nanoparticle transport across tumour-associated biological barriers: in vitro models, imaging, and quantification

Integrating insights from advanced in vitro modelling and cutting-edge detection strategies, this review highlights the current landscape and future directions for optimising the study of gold nanoparticle delivery across barriers in cancer nanomedicine.

Royal Society of Chemistry

Inference Sandbox

Click to select Spheroid Image

The Mission

We believe that the future of oncology lies in the synergy between biological complexity and computational clarity.

Traditional drug discovery is often slowed by the "observation gap"—the delay between treatment and measurable outcome. Our lab is dedicated to closing that gap. By leveraging 3D spheroid models and XAI-validated neural networks, we provide researchers with real-time, non-invasive insights that were previously invisible.

Our goal is to transform every microscopy image into a rich data stream, accelerating the journey from the laboratory bench to the patient’s bedside.

50k+

Spheroids Analyzed

12

Global Partnerships
Lab Personnel // 2026

Our Researchers

Prof. Hirak Patra

Prof. Hirak Patra

Principal Investigator

Advanced Therapeutics in Oncology

Dr. Mark Chen

Dr. Mark Chen

Lead AI

AI & Computer Vision

Dr. Mark Chen

Dr Alexandru Chivu

Biological Lead

Oncology & 3D Cell Models

Sarah Jenkins

Mr Thomas Lester

Research technician

Optical Imaging

Bridging Biology and AI

Our study demonstrates that machine learning does not have to be a "black box." By proving that our models focus on actual necrotic fragmentation, we provide researchers with a tool that is as interpretable as it is powerful.